Drugs / PF-07242813
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04668066 | Dec 2020 → Dec 2022 | atopic eczema | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07242813 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04668066 ↗ |
| Route | Intravenous | “PF-07242813 given intravenously” NCT04668066 ↗ |